Skip to content

Radioimmunoassay Immunoglobulins D.E

by Clinetics Corp.

510(k) K830357

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK830357 Date17 Mar 1983ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DGC
Device Class
Class II
Regulation
21 CFR Part 866.5510
Advisory Committee
Immunology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

Radioimmunoassay Immunoglobulins D.E is a Class II medical device used for the detection and quantification of immunoglobulins D and E via radioimmunoassay methodology. It functions as an in vitro diagnostic tool for immunological analysis.

The device is supplied as a diagnostic reagent system and is regulated under FDA 510(k) clearance K830357, with product code DGC and regulation number 866.5510. It is intended for use in clinical laboratory settings and is not described as sterile, single-use, reusable, or MRI-safe in the provided data.

Other devices from Clinetics Corp.

See all devices from Clinetics Corp. →

Questions

AI-generated answers, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Radioimmunoassay Immunoglobulins D.E used for?

    The Radioimmunoassay Immunoglobulins D.E is used for the detection and quantification of immunoglobulins D and E in clinical laboratory settings via radioimmunoassay methodology, serving as an in vitro diagnostic tool for immunological analysis.

  • How is the Radioimmunoassay Immunoglobulins D.E supplied and what is its regulatory status?

    The device is supplied as a diagnostic reagent system and is regulated under FDA 510(k) clearance K830357, with product code DGC and regulation number 866.5510, indicating it is a Class II medical device substantially equivalent to a predicate device.

  • Is the Radioimmunoassay Immunoglobulins D.E sterile, single-use, or reusable?

    The provided data does not describe the Radioimmunoassay Immunoglobulins D.E as sterile, single-use, or reusable; therefore, no claims about sterility or reusability can be made based on the available information.